Skip to main content

Baltimore company raises $19.4M to change the treatment of brain diseases

The $19.4 million will give the 17-person team the funds necessary to workshop and develop prototypes as the company hopes to start in-person trials in 2024.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.